Eric Solovy – IPPI: The IP Policy Institute

[Archived Post] Policy Brief: The TRIPS Waiver for COVID-19 Vaccines, and Its Potential Expansion: Assessing the Impact on Global IP Protection and Public Health

Posted on: December 14, 2022May 13, 2026Patents , Pharma

This policy brief, including the following “Introduction and Executive Summary,” comes from Eric M. Solovy. CLICK HERE to read the brief in full. Introduction and Executive Summary On June 17, […]